Glenn Sobotka - 04 Nov 2021 Form 4 Insider Report for agilon health, inc. (AGL)

Role: Chief Accounting Officer
Signature: /s/ Lyn Amor Macaraeg, as Attorney-in-Fact
Issuer symbol: AGL
Transactions as of: 04 Nov 2021
Net transactions value: -$2,643,000
Form type: 4
Filing time: 12 Nov 2021, 15:17:18 UTC
Next filing: 29 Sep 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AGL	Common Stock	Options Exercise	$1,135,500	+150,000	+4601%	$7.57	153,260	04 Nov 2021	Direct	F1
transaction	AGL	Common Stock	Sale	$3,778,500	-150,000	-98%	$25.19	3,260	04 Nov 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AGL	Options (Rights to Buy)	Options Exercise	$0	-150,000	-100%	$0.000000^*	0	04 Nov 2021	Common Stock	150,000	$7.57	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes restricted stock units.
F2	These options were granted on February 9, 2019, and fully vested on September 14, 2021.